Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Topical anaesthesia in strabismus surgery for Graves' orbitopathy: a comparative study of 111 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Viral and Genomic Drivers of Squamous Cell Neoplasms Arising in the Lacrimal Drainage System

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Factors associated with ocular surface disease and severity in adults with atopic dermatitis: a nationwide survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Patients presenting with metastases: stage IV uveal melanoma, an international study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Ocular graft-versus-host disease (oGVHD) contributes substantially to morbidity after allogeneic haematopoietic stem cell transplantation (HSCT) but is sparsely investigated in children. We assessed incidence and risk factors for oGVHD and dry eye disease (DED) in a nationwide, single-centre study of 484 consecutive children receiving HSCT during the period 1980-2016. Ophthalmological examinations were performed before and annually at least until five years after HSCT. Twenty-five patients had DED before transplantation (5.6%). The cumulative incidence was 1.9% for acute oGVHD, 6.0% for chronic oGVHD, 8.7% for new onset DED, and 12.7% for new onset Corneal Fluorescein Staining (CFS). In adjusted Fine-Gray regression models, the use of Busulfan was a risk factor for developing acute oGVHD (HR 5.01, p = 0.03), and malignant disease was a risk factor for developing CFS (HR 2.00, p = 0.047). Younger recipient age was associated with reduced risk of DED when comparing children aged 0-4 years with 10-16 years (HR 0.33, p = 0.03). These data underscore the need of attention to DED and oGVHD in relation to HSCT leading to our recommendation of performing ophthalmic examinations in all children before HSCT, and after HSCT when needed, in order to secure diagnosis and treatment of these complications.

Original languageEnglish
JournalBone Marrow Transplantation
Volume57
Issue number3
Pages (from-to)487-498
Number of pages12
ISSN0268-3369
DOIs
Publication statusPublished - Mar 2022

Bibliographical note

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

    Research areas

  • Child, Dry Eye Syndromes/epidemiology, Fatigue Syndrome, Chronic/etiology, Graft vs Host Disease/diagnosis, Hematopoietic Stem Cell Transplantation/adverse effects, Humans, Incidence, Risk Factors

ID: 78115204